Robotic surgery in gynecology: is the future already here?
Georgios GitasLars HankerAchim RodyJohannes Ackermannİbrahim AlkatoutPublished in: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (2022)
Robotic-assisted surgery has gained widespread acceptance in the surgical community and appears to be the most rapidly developing sector of minimally invasive surgery. However, robotic surgery has been viewed as a development of, or alternative to, laparoscopic surgery and not necessarily as a superior technology. The advantages of MIS over open surgery apply to robotic-assisted surgery as well. Nevertheless, conflicting data have been published about the advantages and disadvantages of robotic-assisted and laparoscopic surgery. In the last few years, robotic-assisted surgery has been used for various gynecological procedures such as hysterectomy, lymphadenectomy, myomectomy, sacrocolpopexy or endometriosis operations. In the present review, we analyze the current use of robotic-assisted surgery and its efficiency in gynecology. Patient-based outcomes, such as quality of life and outcomes in morbidly obese patients are also addressed. The potential benefits of single-port robotic-assisted surgery are discussed. Most of the studies published so far state that robotic-assisted surgery does not essentially improve the surgical outcome compared to conventional laparoscopic surgery. However, randomized studies are scarce. Ongoing technological progress over the next few years may improve robotic-assisted techniques and thus optimize the patient's treatment.
Keyphrases
- minimally invasive
- laparoscopic surgery
- coronary artery bypass
- obese patients
- surgical site infection
- bariatric surgery
- healthcare
- clinical trial
- randomized controlled trial
- adipose tissue
- percutaneous coronary intervention
- squamous cell carcinoma
- type diabetes
- early stage
- robot assisted
- risk assessment
- coronary artery disease
- metabolic syndrome
- acute coronary syndrome
- human health
- electronic health record
- climate change
- glycemic control
- phase ii
- smoking cessation